A61K 9/2833
Organic macromolecular compounds
Official title: {Organic macromolecular compounds}
A61K9/2833 (Organic macromolecular compounds) appears on 2,556 US grants and 4,645 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,556
- Published applications
- 4,645
- Assignees
- 1,476
- Inventors
- 6,884
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 6 | 0 |
| 1980 | 3 | 0 |
| 1981 | 10 | 0 |
| 1982 | 6 | 0 |
| 1983 | 7 | 0 |
| 1984 | 13 | 0 |
| 1985 | 13 | 0 |
| 1986 | 8 | 0 |
| 1987 | 14 | 0 |
| 1988 | 10 | 0 |
| 1989 | 16 | 0 |
| 1990 | 16 | 0 |
| 1991 | 16 | 0 |
| 1992 | 15 | 0 |
| 1993 | 15 | 0 |
| 1994 | 17 | 0 |
| 1995 | 26 | 0 |
| 1996 | 30 | 0 |
| 1997 | 33 | 0 |
| 1998 | 33 | 0 |
| 1999 | 23 | 0 |
| 2000 | 46 | 0 |
| 2001 | 45 | 20 |
| 2002 | 45 | 63 |
| 2003 | 51 | 125 |
| 2004 | 41 | 164 |
| 2005 | 31 | 184 |
| 2006 | 33 | 153 |
| 2007 | 28 | 164 |
| 2008 | 26 | 173 |
| 2009 | 29 | 180 |
| 2010 | 65 | 215 |
| 2011 | 63 | 217 |
| 2012 | 80 | 173 |
| 2013 | 126 | 221 |
| 2014 | 159 | 252 |
| 2015 | 127 | 252 |
| 2016 | 135 | 241 |
| 2017 | 160 | 237 |
| 2018 | 118 | 192 |
| 2019 | 113 | 201 |
| 2020 | 133 | 197 |
| 2021 | 125 | 202 |
| 2022 | 110 | 193 |
| 2023 | 91 | 175 |
| 2024 | 98 | 176 |
| 2025 | 82 | 161 |
| 2026 | 53 | 114 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- Anticancer compositions29 Sep 2026US 12,746,230 B2Aragon Pharmaceuticals, Inc.
- Delayed release compositions22 Sep 2026US 12,740,951 B2Amneal Complex Products Research LLC
- Soluble pharmaceutical compositions comprising salts of disubstituted 1, 2, 4-triazine compound22 Sep 2026US 12,740,987 B2Mineralys Therapeutics, Inc.
- Losartan-containing micro tablet for pediatric applications15 Sep 2026US 12,734,131 B2Midas Pharma GmbH
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
- Natural aqueous film-forming composition based on a pair of starches1 Oct 2026US 2026/0294815 A1Swiss Applied Coating Research GmbH
- Methods of treating erythropoietic protoporphyria or x-linked protoporphyria with bitopertin1 Oct 2026US 2026/0294899 A1Disc Medicine, Inc.
- Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide1 Oct 2026US 2026/0294904 A1Hoffmann-La Roche Inc.
Most cited
By later US patents
- Controlled release formulations coated with aqueous dispersions of acrylic polymers1,011US 5,639,476 AEuro-Celtique S. A. · 1997
- Swelling modulated polymeric drug delivery device706US 5,120,548 AMerck & Co., Inc. · 1992
- Sustained release drug delivery devices481US 5,378,475 AUniversity of Kentucky Research Foundation · 1995
- Controlled-release formulations coated with aqueous dispersions of ethylcellulose445US 5,472,712 AEuroceltique, S.A. · 1995
- Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer438US 5,273,760 AEuroceltigue, S.A. · 1993